Drugs / C31510
last change May 2014 re-read 3 minutes ago

C31510

Developed for
cancer
Investigated by
BPGbio

Trials 1

20112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT01251562 Jan 2011 → Aug 2012 cancer BPGbio Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as C31510 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01251562 ↗
Route Intravenous “single 4-hour IV infusion” NCT01251562 ↗